EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC 4.0

Gepants for headache prevention in children and adolescents: A multicenter chart review study

Lauren Shin iD, Olivia Mentz, Amy A Gelfand iD, Blanca Marquez de Prado iD, Hannah Shapiro, Ann Oh iD, Ogo-Oluwa Onifade, Jessica Saunders, Nichelle Raj, Christina L Szperka iD

Headache: The Journal of Head and Face Pain · 2026-01 · 66 (1) · 239-248

DOI: 10.1111/head.15087 ↗

At a glance

Multizentrische Studie in Headache: The Journal of Head and Face Pain, published online on 2025-11-14. Written by Lauren Shin and 9 co-authors. Institution: Benioff Children's Hospital-Child & Adolescent Headache Program, University of California-San Francisco, San Francisco, California, USA. Major MEDLINE topics: Calcitonin Gene-Related Peptide Receptor Antagonists, Pyridines, Piperidines, Headache. Cited 8 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NINDS NIH HHS, NICHD NIH HHS, Nathalie and Nicolas Giauque.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

There is an unmet need for safe, evidence‐based pharmacologic treatments for migraine prevention in children and adolescents. Rimegepant and atogepant, calcitonin gene‐related peptide receptor antagonists (gepants), have been shown to be efficacious and well‐tolerated preventive treatments in adults with migraine. While we await the results of randomized trials in children and adolescents, this study aimed to provide real‐world evidence on the safety and effectiveness of rimegepant and atogepant as preventive headache treatments for youth.

Methods

This was a multisite retrospective chart review study. Sites included Children's Hospital of Philadelphia, Cincinnati Children's Hospital, and University of California San Francisco Benioff Children's Hospital. Inclusion criteria were patients under 18 years of age who were prescribed rimegepant and/or atogepant for preventive treatment. At University of California San Francisco Benioff Children's Hospital and Children's Hospital of Philadelphia, charts of all patients prescribed atogepant, as well as those prescribed rimegepant without a specified “as needed” indication, were reviewed. Data collection at Cincinnati Children's Hospital was a convenience sample based on providers' knowledge. Clinical and demographic data both before and after gepant treatment were abstracted into Research Electronic Data Capture. Descriptive statistics were used to summarize clinical observations.

Results

Of 71 patients who met inclusion criteria, 26 used atogepant and 55 used rimegepant— including 10 who used both. The majority were adolescent females. Migraine was the most common diagnosis. Median number of previous preventive trials was six (interquartile range: 4–8) in the rimegepant group and seven (interquartile range: 5–8) in the atogepant group. Fifty‐eight percent (32/55) of the rimegepant group and 43% (11/26) of the atogepant group saw at least some benefit. Four of 55 patients reported side effects with rimegepant—constipation, nausea, abdominal pain, fatigue, and transient worsening of headache ( n = 1 for each; one patient reported abdominal pain and fatigue). Seven of 26 patients reported side effects with atogepant—nausea (2/26), fatigue (2/26), constipation (1/26), depressed mood (1/26), and feeling cold (1/26). No serious side effects were reported. An exploratory analysis for factors associated with response suggests that a longer headache history has a higher likelihood of benefit (odds ratio 1.41, 95% confidence interval: 1.07–1.85, p = 0.014), and in contrast, more severe limitations in functionality has lower likelihood of benefit (odds ratio 0.18, 95% confidence interval: 0.05–0.58, p = 0.004).

Conclusions

In this real‐world evidence study, gepants for headache prevention in youth were generally well tolerated. Despite failure of multiple prior therapies, some patients benefited from these treatments. This small study was not designed to directly compare the effectiveness of the two medications. Both safety and efficacy in this population need further evaluation in randomized controlled trials.

Subjects

MeSH terms (MEDLINE)

Calcitonin Gene-Related Peptide Receptor AntagonistsPyridinesPiperidinesHeadacheMigraine DisordersHumansAdolescentChildMaleFemaleRetrospective Studies

Author keywords

adolescentcalcitonin gene‐related peptidechildrengepantsmigraine

Substances

Calcitonin Gene-Related Peptide Receptor AntagonistsPyridinesPiperidinesrimegepant sulfate

Authors and institutions

  • Benioff Children's Hospital-Child & Adolescent Headache Program, University of California-San Francisco, San Francisco, California, USA.
  • Pediatric Headache Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Headache Center, Cincinnati Children's Hospital & Medical Center, Cincinnati, Ohio, USA.

ORCID profiles: Lauren Shin, Amy A Gelfand, Blanca Marquez de Prado, Ann Oh, Christina L Szperka

Funding

  • NINDS NIH HHS
  • NICHD NIH HHS
  • Nathalie and Nicolas Giauque
  • National Institute of Child Health and Human Development
  • National Institute of Neurological Disorders and Stroke
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Cite

APA

Shin, L., Mentz, O., Gelfand, A. A., de Prado, B. M., Shapiro, H., Oh, A., Onifade, O. O., Saunders, J., Raj, N., & Szperka, C. L. (2026). Gepants for headache prevention in children and adolescents: A multicenter chart review study. Headache: The Journal of Head and Face Pain, 66(1), 239-248. https://doi.org/10.1111/head.15087

Vancouver

Shin L, Mentz O, Gelfand AA, de Prado BM, Shapiro H, Oh A, et al. Gepants for headache prevention in children and adolescents: A multicenter chart review study. Headache: The Journal of Head and Face Pain. 2026;66(1):239-248. doi:10.1111/head.15087

BibTeX
@article{Shin2026,
  author = {Shin, Lauren and Mentz, Olivia and Gelfand, Amy A and de Prado, Blanca Marquez and Shapiro, Hannah and Oh, Ann and Onifade, Ogo-Oluwa and Saunders, Jessica and Raj, Nichelle and Szperka, Christina L},
  title = {Gepants for headache prevention in children and adolescents: A multicenter chart review study},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  volume = {66},
  number = {1},
  pages = {239--248},
  doi = {10.1111/head.15087}
}
Start for free →